Belluscura fuels growth in Asia
By HME News Staff
Updated 10:05 AM CDT, Mon April 3, 2023
LONDON and PLANO, Texas – Belluscura has started manufacturing its X-PLOR portable oxygen concentrator in China. This follows a manufacturing agreement announced in March 2022 with InnoMax Medical Technology to manufacture the X-PLOR in China, enabling the company to accelerate its international expansion by opening up markets in Asia and beyond. "We continue to make good progress, with manufacturing in China commencing, increased orders for X-PLOR and the tremendous reception of DISCOV-R by the industry at Medtrade," said Robert Rauker, CEO. The DISCOV-R, which is scheduled to launch in the U.S. this summer, was awarded the Silver Award in the New Product Pavilion at Medtrade, March 26-28 in Dallas. Belluscura expects to receive regulatory approval and distribution in China over the summer. The company expects strong growth in Asia Pacific, with nearly 100 million people in China with chronic obstructive pulmonary disease and the oxygen concentrator market expected to reach $1 billion by 2027.
Comments